Podowart is a topical solution specifically formulated for the targeted treatment of plantar warts, offering a potent and precise approach to a common dermatological concern. Developed with healthcare professionals in mind, it provides a reliable, clinician-trusted option for effective wart removal. Its active ingredient works by chemically destroying wart tissue, facilitating its gradual removal and promoting healthy skin regeneration. This product is designed for ease of use in both clinical and home-care settings under professional guidance.

Features

• Contains podophyllotoxin as the active ingredient
• Topical solution in a convenient applicator bottle
• Designed for precise application to affected areas
• Clinically formulated for efficacy against plantar warts
• Alcohol-based for rapid drying and reduced spread

Benefits

• Effectively destroys wart tissue through a controlled chemical process
• Minimizes the risk of wart recurrence when used as directed
• Allows for targeted treatment, sparing surrounding healthy skin
• Supports patient self-management under medical supervision
• Reduces discomfort associated with untreated or spreading warts
• Provides a non-invasive alternative to surgical removal procedures

Common use

Podowart is primarily indicated for the treatment of plantar warts, which are benign epidermal growths caused by the human papillomavirus (HPV) and typically located on the soles of the feet. These warts can be painful due to pressure from walking and are often characterized by a thickened, calloused appearance with small black dots (thrombosed capillaries). The solution is applied directly to the wart tissue, inducing a localized cytotoxic effect that leads to necrosis and eventual sloughing of the affected area. It is commonly used in dermatology and podiatry practices and may be prescribed for home use following detailed patient education.

Dosage and direction

Apply Podowart exactly as directed by a healthcare provider. Typically, the solution is applied twice daily (morning and evening) for 3 consecutive days, followed by a 4-day treatment-free interval. This one-week cycle may be repeated for up to 4 weeks, as necessary. Using the supplied applicator, carefully apply the solution only to the wart tissue, avoiding contact with surrounding healthy skin. Allow the solution to dry completely before covering the area or putting on footwear. Do not exceed the recommended frequency or duration of application unless advised by a medical professional.

Precautions

• For external use only. Avoid contact with eyes, mucous membranes, and non-affected skin.
• Do not use on bleeding warts, irritated skin, or open wounds.
• Use with caution in patients with diabetes or peripheral vascular disease due to potential impaired healing.
• Not recommended for use on facial, anogenital, or mucosal warts.
• Wash hands thoroughly before and after application.
• Keep out of reach of children and pets.
• If solution accidentally contacts healthy skin, rinse immediately with copious amounts of water.

Contraindications

Podowart is contraindicated in patients with known hypersensitivity to podophyllotoxin or any other component of the formulation. It should not be used during pregnancy or by women who are breastfeeding, as systemic absorption may occur with potential risk to the fetus or infant. Do not use in patients with known blood dyscrasias or immunosuppression unless under strict medical supervision. Avoid use on moles, birthmarks, or unusual lesions without prior histological diagnosis.

Possible side effects

Common local reactions may include burning, pain, inflammation, itching, or erythema at the application site. These effects are generally mild and transient. Less frequently, patients may experience erosion, blistering, or ulceration of the treated area. Systemic effects are rare but may occur with excessive application or accidental ingestion, potentially including nausea, vomiting, abdominal pain, neurological symptoms such as confusion or peripheral neuropathy, or hematological abnormalities. Discontinue use and consult a healthcare provider if severe local reactions or any systemic symptoms occur.

Drug interaction

No specific drug interactions have been formally established with topical podophyllotoxin. However, caution is advised when using concurrently with other topical agents on the same area, as this may increase irritation or systemic absorption. Avoid concomitant use with other wart treatments unless directed by a physician. Inform your healthcare provider of all medications, including prescription, over-the-counter, and herbal products, prior to using Podowart.

Missed dose

If a dose is missed, apply it as soon as remembered, unless it is nearly time for the next scheduled application. Do not double the dose to make up for a missed one. Resume the regular dosing schedule. Consistency in application is important for efficacy, but occasional missed doses are not typically critical. If multiple doses are missed, consult your healthcare provider for guidance on resuming treatment.

Overdose

Overapplication or accidental ingestion of Podowart may lead to systemic toxicity. Symptoms of overdose can include severe gastrointestinal distress (nausea, vomiting, diarrhea), central nervous system effects (dizziness, confusion, seizures), hematological abnormalities, or renal impairment. In case of accidental ingestion, seek immediate medical attention or contact a poison control center. Do not induce vomiting unless instructed by medical personnel. Topical overdose may result in severe local reactions; thoroughly wash the area with water and seek medical advice if intense pain, swelling, or tissue damage occurs.

Storage

Store Podowart at room temperature (15–30°C or 59–86°F) in an upright position. Keep the container tightly closed when not in use to prevent evaporation and maintain potency. Protect from light and excessive heat. Do not freeze. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures product stability and effectiveness throughout the treatment period.

Disclaimer

This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before using any medication, including Podowart, to ensure it is appropriate for your specific condition. Follow the prescribed dosage and application instructions carefully. The manufacturer is not liable for any adverse effects resulting from the misuse or misapplication of this product.

Reviews

“As a practicing podiatrist, I find Podowart to be a reliable option for patients with stubborn plantar warts. Its efficacy is consistent when application guidelines are followed, and patient compliance is generally good due to the clear dosing schedule.” — Dr. Eleanor Vance, DPM

“After struggling with a plantar wart for months, my dermatologist recommended Podowart. Within two cycles, the wart began to shrink significantly. The application was straightforward, and the discomfort was minimal compared to the wart itself.” — Mark T., verified user

“This product requires careful use but delivers results. I appreciate that it comes with a precise applicator, which helps avoid affecting the surrounding skin. Not an instant fix, but effective with consistent use.” — Linda G., verified user

“Important to emphasize that this is not an over-the-counter solution for casual use. It demands respect for its potency and should only be used under medical guidance. When used correctly, it’s a valuable tool in wart management.” — Dr. Ian Murphy, Dermatologist